Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials

Area of Science:

• Psychopharmacology
• Clinical Psychology
• Neuroscience

Background:

• Psychedelic research is expanding, attracting significant scientific and public attention.
• Key limitations in current psychedelic clinical trials include expectancy effects and challenges in masking treatment conditions.
• Addressing these methodological issues is crucial for accurate interpretation of study findings.

Purpose of the Study:

• To review the methodological challenges inherent in conducting psychedelic clinical trials.
• To provide actionable recommendations for enhancing the rigor and validity of future psychedelic research.
• To identify strategies for mitigating bias in psychedelic therapy studies.

Main Methods:

• Review of existing literature on psychedelic clinical trial methodologies.
• Analysis of unique sources of bias in psychedelic research, including expectancy and unmasking.
• Discussion of strategies for improving study design, participant selection, and placebo controls.

Main Results:

• Psychedelic trials face unique biases due to pronounced subjective effects, making masking difficult.
• Media hype and participant expectations can significantly influence perceived treatment benefits, leading to placebo/nocebo effects.
• Recommendations focus on optimizing masking, managing participant expectations, and refining study protocols.

Conclusions:

• Implementing recommended design elements can reduce bias in psychedelic clinical trials.
• Enhanced rigor allows for better discernment of treatment-specific effects of psychedelic therapies.
• Improving methodological standards is essential for advancing the field of psychedelic medicine.